Clinical Trials Directory

Trials / Completed

CompletedNCT01899573

Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function

A Study of Percutaneous Left Ventricular Reshaping of Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve LV Function Using the Accucinch® System

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Ancora Heart, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is designed to demonstrate the safety, feasibility and potential efficacy of using the AccuCinch® System to reduce functional mitral regurgitation.

Conditions

Interventions

TypeNameDescription
DEVICEAccuCinch® Ventriculoplasty SystemPercutaneous intervention for the treatment of functional mitral regurgitation

Timeline

Start date
2013-10-01
Primary completion
2016-01-01
Completion
2016-03-01
First posted
2013-07-15
Last updated
2017-06-08

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT01899573. Inclusion in this directory is not an endorsement.

Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function (NCT01899573) · Clinical Trials Directory